Medication info
Hyutekan Tablet 8mg (Candesaritan Cilexetil)

Hyutekan Tablet 8mg (Candesaritan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›8mg / 1 tablet
Manufacturer / importer
Korea Hyutecs Pharmaceutical Co., Ltd.
Appearance
Light pink, round tablets with a convex surface on both sides.
Packaging
30 tablets/bottle. 100 tablets/bottle
Approval status
Active

MFDS item code 201706148 · Approved 2017.07.24 · Insurance code 649103570

Summary

Main use
Treatment of essential hypertension and heart failure with left ventricular systolic dysfunction
Who takes it
Adults · Children
Adult dose
This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No dose adjustment is necessary.
Child dose
1. Essential hypertension Adolescents and children 18 years of age or younger: Safety and efficacy have not been established. 2. Heart failure Adolescents and children 18 years of age or younger: Safety and efficacy have not been established.

Ingredients

Manufacturer
Korea Hyutecs Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with left ventricular systolic dysfunction

  • Essential hypertension
  • heart failure
  • impaired left ventricular systolic function
  • decreased left ventricular ejection fraction
View approved original text

This medication is used to control blood pressure in patients with essential hypertension and is used as an additional treatment for patients with heart failure and impaired left ventricular systolic function who do not achieve sufficient efficacy with ACE inhibitors or cannot tolerate them. It helps in treating essential hypertension and heart failure, improving the patient's condition.

How to take

Adult dose

This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No dose adjustment is necessary.

Child dose

1. Essential hypertension Adolescents and children 18 years of age or younger: Safety and efficacy have not been established. 2. Heart failure Adolescents and children 18 years of age or younger: Safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to this medicine or its components, pregnant or nursing women, patients with severe liver impairment, and those with hereditary angioedema should not take this medication. Elderly patients, those with hyperkalemia, patients with liver impairment, heart valve disease, and those with poor kidney function should take this medication with caution, and it is important to monitor potassium and kidney function through regular blood tests. During treatment, side effects such as dizziness, back pain, and respiratory infections may occur, and rarely, serious allergic reactions, renal function deterioration, or blood abnormalities may arise, so consult a doctor immediately if any abnormal symptoms occur. Blood pressure may drop sharply; therefore, patients undergoing dialysis or taking diuretics or antihypertensive medication should start with a small amount and gradually increase the dose at the beginning of treatment. When taken in combination with other antihypertensive medications, this can enhance the blood pressure-lowering effect, so it should be taken as directed by a physician, and when used with specific diuretics, lithium, or non-steroidal anti-inflammatory drugs, kidney function and potassium levels must be monitored carefully. Women planning to become pregnant or who might be pregnant should not take this medication, and it is also advisable to avoid using it while nursing. Safety and efficacy for children and adolescents under 18 years of age have not been established, so it is recommended not to administer it to them. Caution is needed while driving or operating machinery, as dizziness may occur. In case of overdose, symptoms such as symptomatic hypotension, dizziness, and rapid heartbeat may occur, and immediate medical attention is necessary. Keep out of reach of children, and do not transfer to other containers for safety.

Side effects

  • dizziness
  • back pain
  • respiratory infection
  • upper respiratory infection
  • pharyngitis
  • rhinitis
  • fatigue
  • peripheral edema
  • chest pain
  • headache
Show 76 more
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • joint pain
  • proteinuria
  • weakness
  • fever
  • sensory disturbances
  • dyspepsia
  • gastroenteritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyperkalemia
  • hyponatremia
  • hypoglycemia
  • dizziness
  • headache
  • intestinal vascular edema
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • rash
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • joint pain
  • myalgia
  • back pain
  • renal impairment
  • acute kidney injury
  • fever
  • resolution
  • dyspnea
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • syncope
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbances
  • decreased libido
  • forgetfulness
  • loss of appetite
  • increased appetite
  • tinnitus
  • dysgeusia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Light pink, round tablets with a convex surface on both sides.

Package unit

30 tablets/bottle. 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.